Thank you for your message about ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study). You must verify your email address to receive further communication about this trial. Please check your email for a verification message.
We're sorry, your verification code has expired. Please submit another form using the button below to receive communications about your preferred clinical trial study.